Andrin Oswald, pharmaceutical executive. Delaware International Committee of the Red Cross, Nepal, 2002-2003.
Education
Doctor of Medicine, University Geneva, Switzerland, 1999.
Career
Associate principal McKinsey & Company, Switzerland. Chief Executive Officer Speedel Holding AG (acquired by Novartis AG). Chief Executive Officer, Vaccines and Diagnostics division Novartis Institutes for BioMedical Research, Inc.
Global head, development franchises Novartis Pharma, 2008. Assistant to chairman & Chief Executive Officer, head, country pharma organization, country president, South Korea Novartis AG, 2005, Chief Executive Officer, Vaccines and Diagnostics division, since 2008.
Membership
Delaware International Committee of the Red Cross, Nepal, 2002-2003.